Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Liabilities (2020 - 2026)

NeuroPace has reported Total Liabilities over the past 7 years, most recently at $84.4 million for Q1 2026.

  • For Q1 2026, Total Liabilities fell 1.74% year-over-year to $84.4 million; the TTM value through Mar 2026 reached $84.4 million, down 1.74%, while the annual FY2025 figure was $86.5 million, 0.12% changed from the prior year.
  • Total Liabilities for Q1 2026 was $84.4 million at NeuroPace, down from $86.5 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $88.7 million in Q3 2025 and troughed at $65.6 million in Q2 2022.
  • A 5-year average of $81.9 million and a median of $84.5 million in 2024 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: surged 32.09% in 2022 and later fell 1.74% in 2026.
  • Year by year, Total Liabilities stood at $79.3 million in 2022, then rose by 9.67% to $87.0 million in 2023, then fell by 0.42% to $86.6 million in 2024, then fell by 0.12% to $86.5 million in 2025, then fell by 2.42% to $84.4 million in 2026.
  • Business Quant data shows Total Liabilities for NPCE at $84.4 million in Q1 2026, $86.5 million in Q4 2025, and $88.7 million in Q3 2025.